The levels of serum tumor markers declined significantly after operation.
肿瘤根治术后，肿瘤标记物显著下降；
To investigate the diagnostic value of serum tumor markers in the periampullary carcinoma.
探讨多项肿瘤标志物联合检测对壶腹部周围癌的诊断及鉴别诊断的价值。
Objective To explore value of the serum tumor markers in early stage diagnosis of ovarian cancer.
目的探索血清肿瘤标志物联合检测在卵巢癌诊断中的应用价值。
Objective To evaluate the value of serum tumor markers in diagnosis and following up of pancreatic cancer.
目的评价血清学肿瘤标记物对胰腺癌诊断和随访的价值。
Role of combined Testing of Serum Tumor Markers in the Diagnosis and Treatment of Pancreatic Adenocarcinoma.
血清肿瘤标记物联合检测在胰腺癌诊治中的作用。
Objective To study the correlation between blood serum tumor markers and TCM syndromes of colorectal cancer.
目的研究血清肿瘤标志物的变化与结直肠癌中医辨证分型的相关性。
OBJECTIVE: To investigate the diagnostic value of serum tumor markers combined with spiral CT scan for lung cancer.
目的：探讨多种肿瘤标记物检测联合CT扫描在肺癌诊断中的价值。
Objective: To assess the value of combined testing of serum tumor markers in the diagnosis of gallbladder carcinoma.
目的：探讨联检血清肿瘤标志物和放射性核素骨显像对诊断乳腺癌骨转移的临床价值。
Conclusion the combined assay of serum tumor markers is valuable in the diagnosis of PHC, especially in negative AFP patients.
结论多项肿瘤标志物联合检测对PHC尤其是AFP阴性PHC的诊断具有重要价值。
Objective To investigate the early diagnostic value of detection of the serum tumor markers in patients with meningeal carcinomatosis .
目的探讨血清肿瘤标记物检测对脑膜癌病早期诊断的意义。
Methods Serum tumor markers of lung cancer group, benign disease group and health control group were detected by chemiluminescence immunoassay (ECLIA).
方法采用电化学发光法(ECLIA)分别对肺癌组、肺部良性疾病组患者及健康人的血清肿瘤标记物浓度进行检测分析。
Utilizing serum tumor markers reasonably to detect lung cancer patients was not only better for diagnose, but also for reasonable detection and avoiding wasting resources.
结论合理利用血清肿瘤标志物检查肺癌患者，既有助于诊断，又可做到合理检查、避免资源浪费。
Conclusion: the combined application of ct and serum tumor markers in ovarian carcinoma detection could improve the sensitivity of diagnosis and its consistency with clinical staging.
结论：CT与血清肿瘤标记物联检可提高对卵巢癌的诊断敏感性和临床分期符合率。
Objective To observe the changes of the levels of serum tumor markers, i. e. CA19-9, CA242 and CEA, and their significance during the interventional chemotherapy for pancreatic carcinoma.
目的观察胰腺肿瘤介入化疗术前后相关血清肿瘤标志物糖链抗原19 9（CA19 9）、糖类抗原2 4 2（CA2 4 2 ）及癌胚抗原（CEA）的水平变化及其意义。
Tumor markers in patients' serum were all negative.
血清肿瘤标志物均为阴性。
Serum CA125 is one of the most widely studied tumor markers by now.
血清CA12 5是迄今研究最广泛的肿瘤标记物之一。
Serum CA125 is one of the most widely studied tumor markers by now.
血清CA12 5是迄今研究最广泛的肿瘤标记物之一。
应用推荐